Latest news
Long-Term OMNIVORE Data Show Durable Treatment-Free Survival After Nivolumab in Advanced RCC - OncLiveOncLive · Thu, 06 Aug 2026 12:18:02 GMTOne Treatment, 36 Weeks: Eupraxia's EP-104GI Shows Durable Response in Early Data as Cash Runway Extends to Late 2028 - kalkine.cakalkine.ca · Mon, 03 Aug 2026 16:16:00 GMTPsilocybin-assisted therapy shows promise for veterans with severe, treatment-resistant PTSD - PsyPostPsyPost · Thu, 30 Jul 2026 14:15:23 GMT